Skip to content
sellModerate cluster of 6

Frederick M. Hudson sold $315k of SUPN

director at SUPERNUS PHARMACEUTICALS, INC.. 7,457 shares at an average of $42.26, traded Aug 14, 2025, filed Aug 18, 2025.

Warning score
49
Value
$315k
7,457 shares
Holdings after
46,307
-14% from before
From 52-week low
+41%
low $29.94, close $42.17
From 52-week high
-1%
high $42.64, as of Aug 14, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $315k at market
    +14
  • Share of holdings sold
    Sold 14% of holdings
    +5
  • Cluster
    6 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +4.2%, 3m +4.9%, 6m +18.3%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

SUPNOct 9, 2026 · close 42.67
Since filing Aug 18, 2025: -0.7%SPY +22.7% · excess -23.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-25-040662, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 14, 2025SOpen-market sale
Common Stock
-7,457$42.26$315k46,307Aug 18, 2025

Related signals

Other insiders at SUPERNUS PHARMACEUTICALS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
40Moderate
SUPNsell 610b5-1
SUPERNUS PHARMACEUTICALS, INC.
Padmanabh P. Bhatt
Sr. VP of IP, CSO
$5.4M
107,250 shares
-160%
43Moderate
SUPNsell 6
SUPERNUS PHARMACEUTICALS, INC.
Frederick M. Hudson
director
$272k
5,369 shares
-8%
45Moderate
SUPNsell 610b5-1
SUPERNUS PHARMACEUTICALS, INC.
Jack A. Khattar
President, CEO
$1.8M
35,000 shares
-4%
53Moderate
SUPNsell 6
SUPERNUS PHARMACEUTICALS, INC.
William Todd Horich
SVP, Commercial Operations
$484k
8,877 shares
-100%
24Weak
SUPNsell 6
SUPERNUS PHARMACEUTICALS, INC.
Frank Mottola
SVP, Chief Tech. Ops. Officer
$87k
1,623 shares
-8%
50Moderate
SUPNsell 7
SUPERNUS PHARMACEUTICALS, INC.
Georges Gemayel
director
$1.0M
18,787 shares
-49%
21Weak
SUPNsell 210b5-1
SUPERNUS PHARMACEUTICALS, INC.
Bethany Sensenig
director
$228k
4,475 shares
-100%
33Weak
SUPNsell 210b5-1
SUPERNUS PHARMACEUTICALS, INC.
Frank Mottola
SVP, Chief Tech. Ops. Officer
$1.0M
20,000 shares
-98%
13Weak
SUPNsell 2
SUPERNUS PHARMACEUTICALS, INC.
Padmanabh P. Bhatt
Sr. VP of IP, CSO
$32k
710 shares
-5%
23Weak
SUPNsell 210b5-1
SUPERNUS PHARMACEUTICALS, INC.
Jack A. Khattar
President, CEO
$3.0M
59,900 shares
-5%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Frederick M. Hudson sold $315k of SUPN | InsiderTell